Annual Financial Report
Montanaro UK Smaller Companies Investment Trust PLC
Annual Report and Accounts 2009
The full Annual Report and Accounts 2009 can be found on the Company's website
www.montanarouksmaller.co.uk
The Montanaro UK Smaller Companies Investment Trust PLC ("MUSCIT") was
launched in March 1995 and is listed on the London Stock Exchange.
Investment Objective
MUSCIT's investment objective is capital appreciation (rather than income)
achieved by investing in small quoted companies listed on the London Stock
Exchange or traded on the Alternative Investment Market ("AIM") and to achieve
relative outperformance of its benchmark, the FTSE SmallCap (excluding
investment companies) Index ("SmallCap").
No unquoted investments are permitted.
Investment Policy
The Company seeks to achieve its investment objective by investing in a
portfolio of quoted UK Smaller Companies. At the time of initial investment, a
potential investee company must be profitable and smaller than the largest
constituent of the HGSC Index, which represents the smallest 10% of the UK
Stock Market by value. At the start of 2009, this was any company below £911
million in size. The Manager focuses on the smaller end of this Index.
In order to manage risk the Manager will normally limit any one holding to a
maximum of 5% of the Company's investments. The portfolio weightings of every
stock are closely monitored to ensure they reflect the underlying liquidity of
the particular company. The Company's AIM exposure is also closely monitored
by the Board and is limited to 30% of total investments with Board approval
required for exposure to be above 25%.
The Manager is focused on identifying high quality niche companies operating
in growth markets. This typically leads the Manager to invest in companies
that enjoy high barriers to entry, a sustainable competitive advantage and
strong management teams. The portfolio is therefore constructed on a "bottom
up" basis and there are no sectoral constraints placed on the Manager.
The Board, in consultation with the Manager, is responsible for determining
the gearing strategy of the Company. Gearing is used to enhance returns when
the timing is considered appropriate. The Company currently has a credit
facility of £15 million through ING Bank. The Board has agreed to limit
borrowings to 25% of shareholders' funds.
Highlights 2009
Results
- Net Asset Value ("NAV") -35.7% (£66m)
- Gross assets -40.0% (£71m)*
- Share price -37.6% (market capitalisation £51m)
- FTSE SmallCap (excluding investment companies) Index -46.9%
Year to 31 Year to
March 2009 31 March
2009
Revenue return on 2,465 1,358
ordinary activities
(£000)
Movement in capital (37,721) (23,586)
reserve (£000)
Revenue return per 7.36p 3.82p
ordinary share
Dividend per ordinary 6.85p 3.65p
share
Total return per (105.18)p (62.48)p
ordinary share
As at 31 Year to
March 2009 31 March
2009
Ordinary share price 153.00p 245.00p
NAV per ordinary share 195.94p 304.52p
*Over the year the Company bought shares for cancellation, which accounted for
a reduction of £308,000 in gross assets.
Chairman's Statement
Highlights 2009
- In the year to 31 March 2009, the NAV of MUSCIT decreased by 36% to 196p
in comparison with a 47% loss by the SmallCap.
- Since launch, the NAV of MUSCIT has increased by 96% in comparison with a
loss of 15% by the Small Cap outperforming by 111%.
- The Board is responsible for the share buy back programme. During the year
145,500 shares were bought for cancellation and 1,828,000 shares were
cancelled from Treasury. There are currently no shares held in Treasury.
Background
I am pleased to present the fourteenth annual report of the Montanaro UK
Smaller Companies Investment Trust (MUSCIT), which was launched in March 1995.
In 1996, the initial investment of £25 million was increased in size through a
£30 million "C" share issue. Net assets now stand at £66 million.
MUSCIT is an attractive vehicle for shareholders to invest in a portfolio of
quoted UK Smaller Companies, which are less well researched and more illiquid
than larger, blue chip companies.
Performance
In the year to 31 March 2009, the NAV of MUSCIT decreased by 35.7% to 195.9p
in comparison with a 46.9% fall by the FTSE SmallCap (excluding investment
companies) Index ("SmallCap").
Since launch, the NAV of MUSCIT has increased by 95.9% in comparison with a
loss of 14.8% by the SmallCap, outperforming by 110.7%.
Discount
The discount of MUSCIT's share price to NAV stood at 21.9% on 31 March 2009 in
comparison with a weighted sector average of 16%. As at 5 June the discount of
MUSCIT's share price to NAV stood at 13.7% (Source: Close Wins Investment
Trusts).
Share Buy Backs
The Board is responsible for the implementation of the share buy back
programme which is undertaken at arms length from the Manager.
During the year 145,500 shares were bought back and cancelled. A breakdown of
shares bought back for cancellation is disclosed in Note 15.
Holding Shares in Treasury
Since December 2003, Investment Trusts have had the right to buy back shares
and hold them in Treasury for re-issue at a later date. This has the benefit
of improving liquidity as well as retaining the opportunity to enhance the net
asset value.
The Board has actively and carefully considered the use of Treasury Shares and
has been among the industry's pioneers. Our policy is to ensure that
shareholders receive a tangible benefit above and beyond an enhanced ability
to manage the liquidity of the shares of MUSCIT. Shares held in Treasury will
only be re-issued at a lower discount than when they were originally purchased
and to produce a positive absolute return. Shares not re-issued will be
cancelled within one year from purchase.
In line with this policy, the Company cancelled 1,828,000 shares, representing
5.18% of the issued capital, that were bought into Treasury in December 2007.
This cancellation had no effect on gross assets. However, the buybacks noted
above accounted for a reduction in gross assets of £308,000. As at 31 March
2009 there were no shares held in Treasury.
Gearing
The Board reviews the level of gearing considered appropriate for the Company
in discussion with the Manager. One of the benefits of investment trusts is
the ability to hold prudent levels of gearing which can enhance investment
returns.
During the course of year, the Board decided to reduce the size of the
facility with ING Bank N.V. from £25m to £15m, a level more appropriate for
the Fund following the recent market declines. At 31 March 2009, £5m was drawn
down at an interest rate of 2.69%.
During the year, net gearing ranged from 3.8% to a net cash position of 3.7%.
At 31 March 2009 the Company had a net cash position of 1.8%.
Value Added Tax (VAT)
In 2004 the Association of Investment Companies (AIC) and J.P.Morgan
Claverhouse (Claverhouse) brought a case against Her Majesties Revenue and
Customs (HMRC) to challenge the VAT charge on management fees paid by
investment companies. Following the successful claim by AIC/Claverhouse,
investors will be aware that the Board of MUSCIT lodged its appeal to recover
both the VAT paid on the investment manager's fees and the interest due.
We are pleased to report that this matter has been brought to a timely
resolution and that during the course of the financial year all due VAT and
associated interest payments were received. A total of £1.3m was split between
the revenue and capital accounts, which had the effect of adding 3.9p to the
NAV. The Board has decided to pay out the revenue element in full, a payment
that the Board considers to be of a non-recurring nature.
Dividend
MUSCIT's primary focus is on capital growth rather than income. It is the
Board's stated policy to endeavour to pay out at least 90% of its income each
year. Accordingly, the Board proposes a final dividend of 6.85p per ordinary
share payable on 14 August 2009 to shareholders on the register at the close
of business on 26 June 2009. As a result of the refund of VAT received on past
managerial fees this dividend includes a non-recurring element of 1.99p per
ordinary share amounting to £666,000.
Corporate Governance
The Directors have thoroughly reviewed the recommendations of the 2008
Combined Code on Corporate Governance (the "Code") and have implemented
procedures where appropriate, such as an annual evaluation of the Board's
performance. Consequently, MUSCIT has complied with the Code throughout the
year except where compliance would be inappropriate given the size and nature
of MUSCIT. Compliance with the Code is included in the Directors' Report.
Directorate Change
Following nine years of outstanding service to the Trust, in particular his
Chairmanship of the Audit Committee, Antony Hardy has announced his decision
to retire and will stand down at this year's AGM. On behalf of the Board, I
would like to thank Antony for his hard work and valuable contribution to the
Company and extend our very best wishes to him for the future.
It was announced in March that Roger Cuming, who is Head of Investments at
Reliance Mutual, would join the Board on 5 June 2009. I would like to warmly
welcome Roger who will make a worthy addition to the Board.
Chairman's Comment
The excesses of the past decade unravelled in a matter of months as the global
economy entered unchartered waters last year. In America, Lehman Brothers was
declared bankrupt, AIG was rescued by the U.S. Government and Citibank shares
fell to $1. In the UK, VAT was cut by 2.5% and the banks lined up for
Government support as the tax payer became the majority shareholder in both
Lloyds and the Royal Bank of Scotland. In Europe, Iceland, Hungary, Latvia and
Ukraine all sought aid from the IMF as Eastern Europe threatened to implode.
Governments were forced to act decisively to restore some semblance of
confidence. The Monetary Policy Committee slashed interest rates from 5.25% to
an all time low of 0.5%. Along with this monetarist activity, fiscal packages
were also introduced to stimulate the economy. In the UK, a £20 billion
package was announced, while in Germany the figure was €31 billion. These
efforts were cast into the shade by February's announcement that the Americans
would commit $787 billion in an effort to revive their economic fortunes.
Hopes that the worst of the downturn could be limited to the financial sector
evaporated over the course of the year. The manufacturing sector in the UK
suffered severely. Despite the Government's policy of "competitive
devaluation" industrial production fell 11% in the year to January 2009.
Inevitably, global markets took fright and it proved to be a dismal year for
UK SmallCap, as the Company's benchmark fell by 47%. To put the last twelve
months into a broader context one needs to look at the Hoare Govett Smaller
Companies Index ("HGSC"), which represents the bottom 10% of the market by
value. 2008 was the second worst year since records began in 1955, only
eclipsed by 1974.
While there are many challenges ahead we think it is important to step back
and remember some important lessons from history. Montanaro's internal studies
suggest that, although UK SmallCap faces a challenging period as the economy
enters recession, it outperforms during the recovery. This movement is
amplified by the lack of liquidity that exacerbates the underperformance
against large stocks on the way down, but works in its favour in bull markets
as investors raise their risk profile and buy small companies.
Looking back through the 55 years of data for the HGSC, there have been seven
discernible bull markets. Excluding the possibly unique bull market which ran
from 1974 to 1987, the average return has been 151% over a life of 54 months.
This equates to an annual return of 23%. Small Companies have not only
delivered substantial absolute returns, but they have also achieved impressive
outperformance against the FTSE AllShare ("LargeCap") over these periods. The
average annual relative outperformance against their larger peers was 7%.
These statistics should give considerable cause for optimism. While past
performance can be no guide to future returns, there is a clear and consistent
message: UK SmallCap delivers sizeable returns in bull markets that outstrip
the returns of other equity classes. Of course we cannot forecast when the
market will finally turn. However, with valuations at twenty year lows, the
benchmark trading below book value and signs that the macro-economic
environment may be stabilising, long-term investors should consider increasing
their investment in UK SmallCap.
David Gamble
Chairman
10 June 2009
Manager's Report
Highlights 2009
- It has been a year in which avoiding the major, high profile disasters has
provided a significant boost to relative performance.
- Although M&A activity evaporated in the second half of the financial year,
the portfolio benefitted from three takeovers in its first six months.
- 71% of our holdings are in companies with a market capitalisation of under
£300 million.
Portfolio Management
The past year has underlined the merits of disciplined, fundamental investing.
While the portfolio has always focused on the highest quality companies, in an
environment where order-book visibility is deteriorating rapidly and access to
credit is uncertain, it has been crucial to think independently and not rely
solely on management guidance or broker forecasts. Our team of analysts has
placed great emphasis on running sensitivity checks on portfolio holdings and
challenging the market's earnings assumptions.
We have focused on investments where we have the greatest conviction, leading
us to reduce the number of holdings from 66 to 61. Where we have seen a real
threat to earnings numbers, or where we have sensed heightening concern over
balance sheet structure we have acted swiftly and decisively to sell
positions. It has been a year in which avoiding the major, high profile
disasters has provided a significant boost to relative performance.
In a market dominated by the banks' efforts to recapitalise their balance
sheets, many of the most significant market casualties have been those
companies which have over-extended themselves. This market has entirely
reappraised balance sheets; the efficient (i.e. geared) balance sheets that
were the order of the day just two years ago are now considered stretched and
threaten the very existence of some companies. The search for "efficient
capital structures" has left a poisonous legacy that has been thoroughly
exposed by both the trading downturn and an intolerant banking system.
We have always focused on the highest quality companies. A crucial element of
this assessment has been a strong emphasis on cash generation and balance
sheet strength. We were aware of this trend towards secure balance sheets and
recognised that the market was not going to give companies the benefit of the
doubt. We sold down holdings that we considered vulnerable. The decision to
sell holdings like DTZ and White Young Green that had both over-extended
themselves during a sustained period of acquisitive growth proved timely.
Despite the challenging environment, there have been some strong drivers to
the overall performance of the portfolio. The most significant contributor to
performance was Dechra Pharmaceuticals which rose 14% over the year. The
distributor of veterinary supplies extended its position as an emerging
manufacturer of veterinary pharmaceutical products as it achieved FDA approval
for products in the U.S. market. Mothercare, the specialist children's
retailer, also held up well in the adverse market conditions. Its shares fell
by just 5%, illustrating that strong consumer propositions can deliver
impressive performance across the economic cycles. We continue to like the
company and believe it will emerge from the current downturn with a
strengthened competitive advantage following the plight of competitors such as
Woolworths and Adams.
Although M&A activity evaporated in the second half of the financial year, the
portfolio benefited from three takeovers in its first six months. The most
significant was Detica, an IT specialist serving the security and financial
services markets. The company, which had been held for over four years, was
bought by British Aerospace at a 55% premium. The other two businesses
acquired were IBS OpenSystems, a software business acquired by Capita and
Gibbs and Dandy, a builder's merchant, acquired by St. Gobain.
Annual Returns
Over the course of the financial year, the FTSE SmallCap Index fell almost
47%. At times the markets were driven by fear. Remarkably, at the height of
the financial drama over nine weeks from mid September 2008 to mid November
2008, our benchmark fell 37%. Investors clearly panicked.
In reporting such significant falls in asset value, it feels a very hollow
achievement to report that the Company has outperformed its benchmark by 11%.
This outperformance demonstrates the merits of a disciplined investment
process that has now led to outperformance for five consecutive years, in
which time returns 40% ahead of the benchmark have been delivered.
This strong relative performance has had an unintended consequence. The
portfolio now has a higher weighting of FTSE 250 holdings than at any time in
the past. At 31 March 2009, 41% of the portfolio was made up of FTSE 250
stocks, which compares to 28% at 31 March 2008 and just 15% in March 2007.
There have been significant changes to the make up of the FTSE SmallCap Index.
Over the last two years, our benchmark has become increasingly populated by
many former FTSE 250 and even FTSE 100 companies which in many cases have been
blighted by difficult trading conditions. Many companies that have replaced
them in the mid-cap index have been the defensive names which have delivered
consistent performance. From our portfolio, Dechra Pharmaceuticals, James
Fisher and eaga have all been promoted in the last year.
We have not felt it necessary to reduce this larger weighting in FTSE 250
Index stocks and believe that, in the present environment, the greater
liquidity that these holdings provide has been helpful. It is important to
note that this has not come about through the purchase of new holdings in the
FTSE 250 but has been achieved organically through good performance. The
companies that have been promoted are therefore companies we have known for
many years. The knowledge, insight and understanding we have built over this
time will, we believe, prove very valuable to sound portfolio performance over
the medium-term.
As the table below illustrates, 71% of our holdings are in companies with a
market capitalisation of under £300 million. We remain committed to investing
in "smaller" companies that are less well researched and where we feel we can
add most value. We believe it is this corner of the market which will be the
primary driver of the future growth of the Company and is consequently the
source of our new ideas.
Market
Capitalisation of
Holdings by value
(31/03/2009)
£0-£50m 12%
£50 - £100m 17%
£100 - £200m 29%
£200 - £300m 13%
£300 - £600m 21%
£600m+ 8%
As a part of our commitment to investing in smaller companies, we continue to
take a measured approach towards the Alternative Investment Market (AIM).
While home to many very small, loss making and foreign domiciled businesses, a
select band of impressive companies can also be found at an early stage in
their development. The twelve AIM companies within this portfolio have proved
to be beneficial to overall portfolio performance. We are encouraged that two
of the holdings (Booker and Hargreaves Services) have stated their intention
to move up to the Full List. For dynamic companies delivering sustainable
growth, AIM should be a stepping stone towards broader recognition and a wider
audience which can only help drive investment returns over the longer-term.
Market Outlook
This recession is proving to be more severe and protracted than commentators
had initially forecast. In this April's Budget the Government revised their
forecast economic contraction for 2009 from -2.25% to -3.5%. This still
appears optimistic in comparison to the bleak estimate of a 5% decline by
PricewaterhouseCoopers. If this latter most pessimistic forecast is proved
correct, economic conditions will be the worst year since 1931. Those readers
who know their history will be aware that this led to a significant electoral
defeat for the Labour Government. With this downturn having a grave impact on
public finances, there would appear to be every chance of history repeating
itself.
Macro-economic news is likely to continue to be bleak throughout 2009.
Unemployment figures are expected to rise inexorably towards the 3 million
level. The consumer is understandably chastened. Recognising the unsustainable
levels of debts that he has carried before he is retrenching. Inevitably, and
not before time, the savings rate has improved. The recent pick up from -1% to
almost 5% will do little to help the beleaguered high street and there is
every reason to expect this rate will move higher still; it reached over 10%
in the 1991/2 recession.
There can be no doubt that markets have proved themselves to be hugely
efficient in calling this downturn. The FTSE SmallCap Index peaked in June
2007, eighteen months before western economies officially entered recession.
At the end of March 2009 our benchmark had registered a peak to trough decline
of 65%.
This highlights a crucial point - markets are forward looking. We would
therefore expect markets to bottom in the middle of the recession,
illustrating the over used but often apt message, that it is always darkest
before the dawn. Although markets tend to seek to discount six to nine months
forward, it remains challenging to identify when we can expect that dawn to
break. It may have done so already.
What we do believe is that there is value in the market. Earnings forecasts
for 2009 remained stubbornly high for too long. Management teams were
generally late to recognise the severity and speed of the downturn and as a
consequence proved to be overly optimistic.
The world changed in autumn last year and we have subsequently seen
recognition of the challenges ahead. UK SmallCap earnings forecasts for 2009
have been cut by approximately 20%. While visibility remains limited and there
remains downside pressure, the numbers in the market place appear more
realistic. It is therefore interesting to note that UK SmallCap is now trading
at a discount to large stocks for the first time in five years. We consider
this a necessary precursor to a reappraisal of the SmallCap investment case by
many who have stood on the sidelines for the last two years.
At the end of March 2009, UK SmallCap was trading at 60% of book value making
it far cheaper to buy companies on the stock market than it is to build them.
As the credit markets re-open we would expect a pick up in M&A activity,
possibly led by overseas buyers. The collapse in sterling makes British
businesses considerably cheaper to buy for many American and European
companies compared to just over a year ago. This would not only help markets
to establish a floor, but it is likely that it would prove beneficial to this
portfolio which has seen more than its fair share of takeovers in the past,
with a total of eighteen over the last three years.
There are some encouraging early signs. It appears that the period of smaller
companies underperforming larger companies might be drawing to a close. Since
the start of 2009, we have seen the FTSE SmallCap Index outperform the FTSE
AllShare Index by over 20%. This not only provides a potentially early
indicator that the tide may finally be turning for UK SmallCap, but reminds
investors of the benefits of a diversified portfolio that includes SmallCap.
Having outperformed for 12 years out of 14, we believe investors are best
rewarded over the longer term by investing with an experienced manager whose
investment process has delivered over several market cycles. At Montanaro, we
have one of the largest dedicated SmallCap research teams and believe that
this resource is the key to generating these consistent returns through bottom
up stock picking.
I would like to record my thanks to our Chairman, Board of Directors and
shareholders for their help and support during this challenging year.
Dan Harlow
Montanaro Investment Managers Limited
10 June 2009
Description of Thirty Largest Holdings
as at 31 March 2009
Dechra Pharmaceuticals PLC
Manufacturer and distributor of veterinary products and pharmaceuticals.
Fisher (James) & Sons PLC
Provider of specialist marine support services and operator of tankships
around UK coastal waters.
Dignity PLC
The UK's largest provider of funeral related services.
BPP Holdings PLC
The leading provider of training services to the legal, accountancy and
financial markets.
Domino's Pizza UK & IRL PLC
The UK and Ireland's leading pizza delivery company.
Hargreaves Services PLC
A leading provider of transport and support services to the energy and waste
sectors.
Latchways PLC
World leader in the design, manufacture and sale of safety systems for
individuals working at height.
Mothercare PLC
The leading global retailer of parenting and children's products.
Ricardo PLC
The leading UK independent automotive consultancy.
Chloride Group PLC
An international provider of secure power solutions for the business
continuity of customers worldwide.
Genus PLC
A world leader in the application of genetics to animal breeding.
NCC Group PLC
A provider of escrow solutions, assurance testing and consultancy.
Albemarle and Bond Holdings PLC
The UK's market leading pawnbroking business.
London Capital Group PLC
A provider of spread-betting products on the financial markets to retail
clients.
James Halstead PLC
A manufacturer of commercial resilient floor-coverings to the worldwide
market.
Brewin Dolphin PLC
The UK's largest independent private client Investment Manager.
eaga PLC
The UK's leading provider of residential energy efficiency solutions.
Barr (AG) PLC
The soft drink group, best known for producing Irn Bru.
Domino Printing Sciences PLC
An international group providing total coding and printing solutions to a wide
portfolio of market sectors.
Wilmington Group PLC
Leading provider of information and training to business and professional
markets, with particular strength in the legal and regulatory sectors.
Care UK PLC
An independent provider of health and social care service solutions.
Croda International PLC
A manufacturer of speciality chemicals for the consumer care and industrial
markets.
BSS Group PLC
A specialist in the marketing and distribution of heating, plumbing, and
mechanical services equipment.
Consort Medical PLC
A leader in medical devices for inhaled drug delivery and anaesthesia.
M.P. Evans Group PLC
A producer of Indonesian palm oil and Australian beef cattle.
Mears Group PLC
A leading social housing repairs and maintenance provider with a growing
presence in the domiciliary care market.
Carclo PLC
A supplier of fine tolerance, injection moulded plastic components which are
used in medical, automotive, telecom and electronics products.
Phoenix IT Group PLC
A provider of a range of IT support services, including Business Continuity,
hosting, service desks, and network and systems management.
Chemring Group PLC
A specialist manufacturer of decoy countermeasures and energetic materials for
the global defence, security and safety markets.
Booker Group PLC
The leading wholesaler for caterers, retailers and businesses.
Fifty Largest Holdings
as at 31 March 2009
Value % of Market Cap
Holding Sector £0 portfolio £m
Dechra Pharmaceuticals PLC Pharmaceuticals and Biotechnology 2,593 4.0 274
Fisher (James) & Sons PLC Industrial Transportation 2,187 3.4 203
Dignity PLC General Retailers 2,145 3.3 342
BPP Holdings PLC Support Services 1,963 3.1 176
Domino's Pizza UK & IRL PLC Travel and Leisure 1,766 2.8 365
Hargreaves Services PLC Support Services 1,757 2.7 112
Latchways PLC Support Services 1,683 2.6 53
Mothercare PLC General Retailers 1,632 2.5 340
Ricardo PLC Support Services 1,600 2.5 102
Chloride Group PLC Electronic and Electrical Equipment 1,513 2.4 326
Ten Largest Holdings 18,839 29.3
Genus PLC Pharmaceuticals and Biotechnology 1,474 2.3 316
NCC Group PLC Software and Computer Services 1,456 2.3 94
Albemarle and Bond Holdings PLC General Financials 1,445 2.3 110
London Capital Group PLC General Financials 1,383 2.1 100
James Halstead PLC Construction and Materials 1,365 2.1 223
Brewin Dolphin PLC General Financials 1,341 2.1 254
eaga PLC Support Services 1,329 2.0 368
Barr (AG) PLC Beverages 1,301 2.0 242
Domino Printing Sciences PLC Electronic and Electrical Equipment 1,259 2.0 205
Wilmington Group PLC Media 1,219 1.9 74
Care UK PLC Health Care Equipment and Services 1,204 1.9 155
Croda International PLC Chemicals 1,193 1.9 722
BSS Group PLC Support Services 1,138 1.8 356
Consort Medical PLC Health Care Equipment and Services 1,082 1.7 97
M.P. Evans Group PLC Food Producers 1,078 1.7 126
Mears Group PLC Support Services 1,044 1.6 161
Carclo PLC Chemicals 1,044 1.6 33
Phoenix IT Group PLC Software and Computer Services 1,044 1.6 109
Chemring Group PLC Aerospace and Defence 1,043 1.6 669
Booker Group PLC Food and Drug Retailers 1,026 1.6 402
Thirty Largest Holdings 43,307 67.4
Ultra Electronics Holdings PLC Aerospace and Defence 1,014 1.6 743
Victrex PLC Chemicals 977 1.5 421
Rensburg Sheppards PLC General Financials 972 1.5 176
Venture Production PLC Oil and Gas Producers 971 1.5 1,197
Mucklow (A&J) Group PLC Real Estate 962 1.5 130
Hill & Smith Holdings PLC Industrial Engineering 930 1.5 118
Caretech Holdings PLC Health Care Equipment and Services 918 1.4 135
Goals Soccer Centres PLC Travel and Leisure 891 1.4 61
WSP Group PLC Support Services 883 1.4 151
Primary Health Properties PLC Real Estate 858 1.3 82
Microgen PLC Software and Computer Services 840 1.3 38
VP Group PLC Support Services 834 1.3 65
RPS Group PLC Support Services 833 1.3 334
The Stanley Gibbons Group PLC General Retailers 831 1.3 23
Zytronic PLC Electronic and Electrical Equipment 818 1.3 17
TR Property Investment Trust PLC Real Estate 722 1.1 49
Hamworthy PLC Industrial Engineering 714 1.1 91
Dana Petroleum PLC Oil and Gas Producers 689 1.1 965
Dialight PLC Electronic and Electrical Equipment 683 1.1 36
Kewill PLC Software and Computer Services 623 1.0 28
Fifty Largest Holdings 60,270 93.9
Analysis of Investment Portfolio by Industrial or Commercial Sector
as at 31 March 2009
Sector % of portfolio % of SmallCap
Oil and Gas Producers 3.1 1.8
Oil Equipment Services and Distribution 0.0 0.0
Oil and Gas Total 3.1 1.8
Chemicals 5.0 1.3
Mining 0.0 2.2
Basic Materials Total 5.0 3.5
Aerospace and Defence 4.0 2.1
Construction and Materials 2.4 4.7
Electronic and Electrical Equipment 6.7 2.0
General Industrials 0.0 1.0
Industrial Engineering 2.8 4.6
Industrial Transportation 3.4 3.7
Support Services 22.4 17.3
Industrials Total 41.7 35.4
Automobiles and Parts 0.0 0.0
Beverages 2.0 0.0
Food Producers 1.7 3.1
Household Goods 0.0 1.7
Leisure Goods 0.1 0.6
Personal Goods 0.0 0.0
Consumer Goods Total 3.8 5.4
Health Care Equipment and Services 5.0 3.7
Pharmaceuticals and Biotechnology 6.3 4.9
Health-care Total 11.3 8.6
Food and Drug Retailers 1.6 0.3
General Retailers 7.2 4.2
Media 1.9 5.7
Travel and Leisure 5.6 5.9
Consumer Services Total 16.3 16.1
Fixed Line Telecommunications 0.0 0.6
Telecommunications Total 0.0 0.6
General Financial 8.0 6.2
Life Insurance 0.0 0.9
Non-life Insurance 0.0 0.9
Real Estate 4.6 12.8
Financials Total 12.6 20.8
Software and Computer Services 6.2 4.9
Technology, Hardware and Equipment 0.0 2.9
Technology Total 6.2 7.8
Total 100.0 100.0
The investment portfolio comprises 61 listed UK equity holdings including 12
holdings totalling £12,541,000 (representing 20% of the portfolio) traded on
the Alternative Investment Market ("AIM").
Directors' Report
The Directors present their Annual Report and financial statements for the
year ended 31 March 2009.
Business Review
Introduction
The purpose of the Business Review is to provide an overview of the business
of the Company by:
- Analysing development and performance using appropriate key performance
indicators (`KPIs')
- Outlining the principal risks and uncertainties affecting the Company
- Describing how the Company manages these risks
- Explaining the future business plans of the Company
- Setting out the Company's environmental, social and ethical policy as
disclosed on page 17
- Providing information about persons with whom the Company has contractual or
other arrangements which are essential to the business of the Company
- Outlining the main trends and factors likely to affect the future
development, performance and position of the Company's business.
DEVELOPMENT, PERFORMANCE AND POSITION OF MUSCIT
Review of the Business of MUSCIT
A description of MUSCIT's activities during the year is given in the
Chairman's Statement on page 2 and in the portfolio management section of the
Manager's Report.
MUSCIT is a closed-end investment trust listed on the London Stock Exchange.
Its affairs are managed so that it receives approval from HM Revenue & Customs
as an investment trust under s842 of the Income & Corporation Taxes Act 1988
("s842"). One of the criteria for compliance is that at least 85% of MUSCIT's
eligible investment income arising in an accounting period is distributed to
shareholders.
The Board considers that MUSCIT will continue to qualify as an investment
trust, which confers certain benefits such as exemption from the payment of
capital gains taxes arising on the sale of investments. MUSCIT has most
recently received approval under s842 for the year ended 31 March 2008 and an
application will be made to HM Revenue & Customs for MUSCIT's status as an
investment trust in financial year 2008/09 to be confirmed. Further details on
the operation of investment trusts can be obtained from the Association of
Investment Companies on their website at www.theaic.co.uk.
MUSCIT is also an investment company as defined in s833 of the Companies Act
2006. The current portfolio of MUSCIT is such that its shares are eligible for
inclusion in an ISA and PEPs up to the maximum annual subscription limit and
the Directors expect this eligibility to be maintained.
MUSCIT's investment objective is capital appreciation (rather than income)
achieved by investing in quoted companies listed on the London Stock Exchange
or traded on the Alternative Investment Market ("AIM"). No unquoted
investments are permitted. The benchmark is the FTSE SmallCap (excluding
investment companies) Index.
At the time of initial investment, a potential investee company must be
profitable and smaller than the largest constituent of the HGSC Index which
represents the smallest 10% of the UK Stock Market by value. At the start of
2009, this was any company below £911 million in size.
The Manager of MUSCIT is Montanaro Investment Managers Limited ("Montanaro"),
a highly experienced specialist in UK and European quoted small companies
established in 1991. Montanaro has one of the largest teams in the UK
researching and investing exclusively in quoted small companies.
They closely monitor all investments within the portfolio and identify
potential new investments. Although sector weightings of the benchmark are
monitored, the portfolio is a result of bottom up stock picking and may differ
markedly from the index. Tracking error may be relatively high reflecting a
focus on research driven stock selection. Montanaro currently manage over £500
million, mainly on behalf of leading financial institutions.
There are currently 33,475,958 ordinary 10p shares in issue (2008: 35,449,458)
of which none are held in Treasury (2008: 1,828,000). Holders of ordinary
shares have unrestricted voting rights at all general meetings of the Company.
Details of the shares bought back during the year are contained in the
Chairman's Statement on page 2 and in Note 15.
Description of Principal Risks Associated with MUSCIT
The Board carefully considers the principal risks for MUSCIT and seeks to
manage these risks through continual and regular review, policy setting,
compliance with and enforcement of contractual obligations and active
communication with the Manager, the Administrator and shareholders.
The Board applies the principles detailed in the recommendations of the AIC
Code as described elsewhere in the Directors' Report. Details of MUSCIT's
internal controls may be found under Corporate Governance.
Mitigation of the principal risks is sought and achieved in many ways as shown
in italics below:
Investment Manager: Montanaro has been the Manager of MUSCIT since its launch
in 1995. The success of MUSCIT and its strong performance is largely
attributable to Montanaro. Should the current Manager not be in a position to
continue its management of the Company, performance may be impacted.
The Board holds board meetings which are attended by the Manager. Montanaro
have one of the largest specialist teams in the UK. Succession planning within
Montanaro and recruitment of personnel are closely monitored.
Investment & Strategy: MUSCIT may underperform its benchmark as a result of
poor stock selection or sector allocation or as a result of being geared in a
falling market.
The Manager meets regularly with the Board to discuss portfolio performance
and strategy, and provides the Board and shareholders with monthly reports.
The portfolio is well diversified thereby reducing stock specific risk. The
Board receives and reviews monthly a report of all transactions and, through
the forum of its Management Engagement Committee, formally reviews the
performance of the Manager annually.
Gearing: one of the benefits of closed ended investment trusts is the ability
to use borrowings which can enhance returns in a rising stock market. However,
gearing exacerbates movements in the net asset value both positively and
negatively and will exaggerate declines in net asset value when prices of
quoted UK small companies are falling.
The Board monitors and discusses with the Manager the appropriate level of
gearing of MUSCIT at each Board meeting.
Portfolio Liquidity: as with all small company investment trusts, there are
times when the liquidity of the underlying portfolio is poor, such as when
small company trusts are out of favour or during periods of adverse economic
conditions. The Manager focuses on Smaller Companies where the opportunities
may be more attractive but this can increase overall underlying illiquidity.
This may result in the Manager being unable to buy or sell individual holdings
within the portfolio. In addition, this may impact the discount of MUSCIT to
the net asset value of the portfolio.
One of the benefits of a closed end investment trust is that the Manager is
not forced to buy or sell individual holdings at inopportune times. The
Manager constantly reviews the underlying liquidity of the portfolio, which is
well-diversified. Particular attention is paid to the AIM holdings, with the
Manager providing the Board with liquidity reports at every meeting. Montanaro
deal with a wide range of brokers to enhance their ability to execute and
minimise liquidity risk.
Liquidity of MUSCIT Shares: as with many small company investment trusts,
there are times when the liquidity of the shares of MUSCIT is low. In the case
of MUSCIT, many of the shareholders are large financial institutions with a
long-term investment horizon. Unlike other trusts where private individuals
form a larger part of the share register, this may result in less shares being
traded in MUSCIT on a daily basis and make it difficult at times for investors
to buy or sell shares of MUSCIT.
The Manager is encouraged by the Board to market the strong investment story
of MUSCIT to private client wealth managers and other potential new investors.
The goal is to widen the shareholder base to enhance liquidity. In addition,
the ability to buy back shares to be held in Treasury for subsequent re-issue
enhances the liquidity of MUSCIT shares.
Discount Volatility: as with all small company investment trusts, discounts
can fluctuate significantly both in absolute terms and relative to their peer
group.
The Board actively monitors and seeks to manage the discount of MUSCIT and is
responsible for share buy backs for cancellation or issuance from Treasury.
Share buy backs may help to reduce the discount.
During the year and up to the date of this report, MUSCIT has made use of the
authority granted at the Annual General Meeting held in 2008 to make market
purchases of up to 5,313,874 ordinary shares and as at the date of this report
has the authority to purchase 5,263,374ordinary shares. No ordinary shares are
currently held in Treasury. 145,500 Ordinary shares were bought back for
cancellation during the year.
The Board encourages the Manager to market MUSCIT to new investors to increase
demand for shares of MUSCIT, which may help to reduce the discount.
Regulatory: a breach of s842 might lead to MUSCIT being subject to capital
gains tax; a breach of rules of the London Stock Exchange might result in
censure by the FSA and/or suspension of MUSCIT's listing on the London Stock
Exchange.
The Board has agreed a service level agreement with the Administrator which
includes active and regular review of
compliance with s842, and FSA and London Stock Exchange Rules. This is
reviewed at each Board meeting.
Operational: if the Administrator's operational procedures proved deficient
and its core accounting systems failed, accounting errors might occur
resulting in inaccurate net asset valuations and performance data and possibly
a qualified audit report and/or loss of s842 status.
The Board monitors operational issues monthly and reviews them in detail at
each Board meeting.
Financial: inappropriate accounting policies or failure to comply with current
or new Accounting Standards might lead to a breach of regulations and/or loss
of s842 status.
The Board monitors financial issues monthly and reviews them in detail at each
Board meeting.
Banking: a breach of MUSCIT's loan covenants might lead to funding being
summarily withdrawn and investment holdings potentially being sold at a time
of poor liquidity.
The main financial covenants to which the Company is subject in respect of the
ING N.V. revolving credit facility require it to ensure that total borrowings
will not exceed 30% of the adjusted Net Asset Value at any time and that the
adjusted Net Asset Value does not fall below £39,000,000 at any time.
The Board monitors compliance with banking covenants monthly and reviews them
with the Administrator and Manager.
Reputational: inadequate or deficient controls of the Administrator or Manager
or other third-party providers might result in breaches of regulations and
damage the trust and confidence of shareholders in MUSCIT, leading to a
widening of the discount.
The Board continually monitors and reviews issues that may impact the standing
of MUSCIT.
Reputational: Failure to keep current and potential investors informed of the
Trust's performance and development could result in less shares being traded
in MUSCIT on a daily basis and also lower investor confidence.
The Board and Manager maintain clear and frequent communication with
shareholders and potential investors. The Board and Manager are happy to meet
with shareholders.
Company Viability: Through falling NAV, or a reduction in the size of the
Company through repurchases of its own shares, the size of the Company could
make the continuing existence of the Company unviable in the opinion of
investors.
The Board actively monitors and seeks to manage the discount of MUSCIT and is
responsible for share buy backs for cancellation or holding in Treasury. The
resultant size of the Company is an important consideration of the decision to
undertake buy backs. The Board regularly reviews the performance of the
Company and the strategy of the Manager is reviewed at each Board meeting.
A description of MUSCIT's system for reviewing its risk-environment is shown
in the Directors' Report.
Statement of Directors' Responsibilities
in Respect of the Annual Report and the Financial Statements
The Directors are responsible for preparing the Annual Report and the
financial statements in accordance with applicable law and regulations.
Company law requires the Directors to prepare financial statements for each
financial year. Under that law they have elected to prepare the financial
statements in accordance with UK Accounting Standards and applicable law (UK
Generally Accepted Accounting Practice).
The financial statements are required by law to give a true and fair view of
the state of affairs of the Company and of the profit or loss of the Company
for that period.
In preparing these financial statements, the Directors are required to:
- select suitable accounting policies and then apply them consistently;
- make judgments and estimates that are reasonable and prudent;
- state whether applicable UK Accounting Standards have been followed,
subject to any material departures disclosed and explained in the financial
statements; and
- prepare the financial statements on the going concern basis unless it is
inappropriate to presume that the Company will continue in business.
The Directors are responsible for keeping proper accounting records that
disclose with reasonable accuracy at any time the financial position of the
Company and enable them to ensure that its financial statements comply with
the Companies Act 1985. They have general responsibility for taking such steps
as are reasonably open to them to safeguard the assets of the Company and to
prevent and detect fraud and other irregularities.
Under applicable law and regulations, the Directors are also responsible for
preparing a Directors' Report, Directors' Remuneration Report and Corporate
Governance Statement that comply with that law and those regulations.
The Directors are responsible for the maintenance and integrity of the
corporate and financial information included on the company's website,
www.montanarouksmaller.co.uk. Legislation in the UK governing the preparation
and dissemination of financial statements may differ from legislation in other
jurisdictions.
Responsibility statement of the Directors in respect of the annual financial
report
We confirm that to the best of our knowledge:
- the financial statements, prepared in accordance with the applicable set
of accounting standards, give a true and fair view of the assets, liabilities,
financial position and profit or loss of the Company; and
- the Directors' Report includes a fair review of the development and
performance of the business and the position of the issuer, together with a
description of the principal risks and uncertainties that they face.
DAVID GAMBLE
Chairman
10 June 2009
Income Statement
for the year to 31 March 2009
Year to 31 March 2009 Year to 31 March 2008
Revenue Capital Total Revenue Capital Total
Notes £000 £000 £000 £000 £000 £000
Losses on investments
designated as fair value
through profit or loss 10 - (37,641) (37,641) - (22,427) (22,427)
Dividends and interest 2 2,855 - 2,855 2,823 - 2,823
Management fee* 3 26 (61) (35) (716) (717) (1,433)
Management performance fee* 3 - 247 247 - - -
Other income 2 184 - 184 5 - 5
Other expenses 4 (334) - (334) (312) - (312)
Net return before finance
costs and taxation 2,731 (37,455) (34,724) 1,800 (23,144) (21,344)
Interest payable and similar charges 6 (266) (266) (532) (442) (442) (884)
Net return before taxation 2,465 (37,721) (35,256) 1,358 (23,586) (22,228)
Taxation 7 - - - - - -
Net return after taxation 2,465 (37,721) (35,256) 1,358 (23,586) (22,228)
Return per ordinary share 9 7.36p (112.54p) (105.18p) 3.82p (66.30p) (62.48p)
The total column of this statement is the profit and loss account of the Company.
All revenue and capital items in the above statement derive from continuing operations.
No Statement of Total Recognised Gains and Losses has been prepared as all
such gains and losses are shown in the Income Statement.
No operations were acquired or discontinued in the year.
* net of VAT refund.
The notes below form part of these financial statements.
Reconciliation of Movements in Shareholders' Funds
for the year to 31 March 2009
Called-up Share Capital Own shares Total equity
share premium redemption Special Capital Revenue held in shareholders'
capital account reserve reserve reserve reserve Treasury funds
Year to 31 March 2009 Notes £000 £000 £000 £000 £000 £000 £000 £000
As at 31 March 2008 3,545 19,307 1,165 9,451 71,169 2,247 (4,501) 102,383
Fair value movement of investments 10 - - - - (37,641) - - (37,641)
Costs allocated to capital - - - - (80) - - (80)
Dividends paid in the year 8 - - - - - (1,227) - (1,227)
Shares purchased for cancellation (14) - 14 (308) - - - (308)
Treasury shares cancelled (183) - 183 (4,501) - - 4,501 -
Net revenue for the year - - - - - 2,465 - 2,465
As at 31 March 2009 3,348 19,307 1,362 4,642 33,448 3,485 - 65,592
Called-up Share Capital Own shares Total equity
share premium redemption Special Capital Revenue held in shareholders'
capital account reserve reserve Reserve reserve Treasury funds
Year to 31 March 2008 £000 £000 £000 £000 £000 £000 £000 £000
As at 31 March 2007 3,561 19,307 1,149 9,835 94,755 1,833 - 130,440
Fair value movement of investments 10 - - - - (22,427) - - (22,427)
Costs allocated to capital - - - - (1,159) - - (1,159)
Dividends paid in the year 8 - - - - - (944) - (944)
Shares purchased for cancellation (16) - 16 (384) - - - (384)
Shares purchased for Treasury - - - - - - (4,501) (4,501)
Net revenue for the year - - - - - 1,358 - 1,358
As at 31 March 2008 3,545 19,307 1,165 9,451 71,169 2,247 (4,501) 102,383
The notes below form part of these financial statements.
Balance Sheet
as at 31 March 2009
31 March 2009 31 March 2008
Notes £000 £000 £000 £000
Fixed assets
Investments designated at
fair value through profit or loss 10 64,207 106,154
Current assets
Debtors 12 344 460
Cash at bank 20 6,167 11,243
6,511 11,703
Creditors: amounts falling
due within one year
Other creditors 13 (126) (474)
Revolving credit facility 14 (5,000) (15,000)
(5,126) (15,474)
Net current assets/(liabilities) 1,385 (3,771)
Total assets less current liabilities 65,592 102,383
Net assets 65,592 102,383
Share capital and reserves
Called-up share capital 15 3,348 3,545
Share premium account 19,307 19,307
Capital redemption reserve 1,362 1,165
Special reserve 4,642 9,451
Capital reserve 33,448 71,169
Revenue reserve 3,485 2,247
Own shares held in Treasury - (4,501)
Total equity shareholders' funds 65,592 102,383
Net asset value per ordinary share 18 195.94p 304.52p
These financial statements were approved by the Board of Directors on 10 June 2009.
DAVID GAMBLE ANTONY HARDY
The notes below form part of these financial statements.
Statement of Cash Flows
for the year to 31 March 2009
31 March 2009 31 March 2008
Notes £000 £000 £000 £000
Operating activities
Investment income received 2,652 2,604
Deposit interest received 313 177
Management fees paid (960) (2,059)
Company secretarial fees paid (79) (63)
VAT and interest reclaimed on
investment management fees 2/3 1,313 -
Other cash expenses (257) (529)
Net cash inflow from
operating activities 19 2,982 130
Servicing of finance
Interest and similar charges paid (686) (802)
Net cash outflow from servicing of finance (686) (802)
Capital expenditure and
financial investment
Purchases of investments (14,400) (28,763)
Sales of investments 18,563 37,647
Net cash inflow from
investing activities 4,163 8,884
Equity dividends paid (1,227) (944)
Net cash inflow before financing 5,232 7,268
Financing
(Repayment)/proceeds of
short-term credit facility (10,000) 4,500
Ordinary shares purchased for cancellation (308) (384)
Ordinary shares purchased for Treasury - (4,501)
Net cash outflow from financing (10,308) (385)
(Decrease)/increase in cash 20 (5,076) 6,883
The notes below form part of these financial statements.
Notes to the Financial Statements
at 31 March 2009
1 Accounting Policies
Accounting Convention
The financial statements are prepared under the historical cost convention as
modified by the revaluation of fixed asset investments and in accordance with
UK applicable accounting standards and the Statement of Recommended Practice
regarding the Financial Statements of Investment Trust Companies and Venture
Capital Trusts ("SORP") issued in January 2009 and adopted early. The early
adoption of this SORP had no effect on the financial statements of the Company
other than the requirement to separately disclose capital reserves that relate
to the revaluation of investments held at the Balance Sheet date. This new
requirement replaces the requirement to disclose the value of the capital
reserve that is unrealised. All the Company's activities are continuing.
A resolution to release the Directors from the requirement of holding a
continuation vote in 2010, as required by the Articles of Association, will be
put to shareholders at the Annual General Meeting as outlined in the Notice of
Annual General Meeting in the full annual report.
Income Recognition
UK dividend income is included in the financial statements when the
investments concerned are quoted ex-dividend and shown net of any associated
tax credit.
Deposit interest and underwriting commissions receivable are included on an
accruals basis.
Management Expenses and Finance Costs
Management fees and finance costs are allocated 50% to the capital reserve and
50% to the revenue account. This is in line with the Board's expectations of
long-term returns from the investment portfolio of the Company. Performance
fees are charged 100% to capital.
Costs arising on early settlement of debt are allocated 100% to capital, in
accordance with the requirements of the SORP.
All other expenses are allocated in full to the revenue account.
Investments
Investments are recognised and derecognised on the trade date where a purchase
or sale is under a contract whose terms require delivery within the time frame
established by the market concerned, and are initially measured at fair value.
All investments held by the Company are classified as at "fair value through
profit or loss". Investments are initially recognised at cost, being the fair
value of the consideration given. After initial recognition investments are
measured at fair value, with unrealised gains and losses on investments and
impairment of investments recognised in the Income Statement and allocated to
capital.
For investments actively traded in organised financial markets, fair value is
generally determined by reference to Stock Exchange quoted market bid prices
at the close of business on the balance sheet date, without adjustment for
transaction costs necessary to realise the asset.
Treasury Shares
The consideration paid for shares held in Treasury is presented as a deduction
from equity shareholders' funds, in accordance with FRS 25: "Financial
Instruments: Disclosure and Presentation". Any profit on the sale of shares
out of Treasury is credited to the share premium account in full.
Taxation
The charge for taxation is based on the net revenue for the year. Deferred
taxation is provided in accordance with FRS 19: Deferred Taxation, on all
timing differences that have originated but not reversed by the balance sheet
date. Deferred taxation assets are only being recognised to the extent that
they are regarded as recoverable.
Dividends Payable to Shareholders
In accordance with FRS 21: "Events after the Balance Sheet date", dividends to
shareholders are recognised as a liability in the period in which they have
been declared. Therefore, any interim dividends are not accounted for until
paid, and final dividends are accounted for when approved by shareholders at
an annual general meeting.
Bank loans and borrowings
All bank loans and borrowings are initially recognised at cost, being the fair
value of the consideration received, less issue costs where applicable. After
initial recognition, all interest bearing loans and borrowings are
subsequently measured at amortised cost. Any differences between cost and
redemption value is recognised in the Income Statement over the period of the
borrowings on an effective interest basis.
CAPITAL RESERVES
In accordance with the guidance given in the AIC SORP issued January 2009 the
capital reserve is not separated into realised and unrealised. Therefore gains
and losses on realisation of investments and changes in fair value of
investments are shown in one reserve.
2 Income Year to Year to
31 March 2009 31 March 2008
£000 £000
Income from investments 2,608 2,628
UK dividend income 2,608 2,628
Other income
Interest received on Investment Management
fees reclaimed VAT 181 -
Bank interest 247 195
Underwriting commission 3 5
Total income 3,039 2,828
Total income comprises
Dividends from financial assets 2,608 2,628
designated at fair value through profit or loss
Interest from financial assets 247 195
designated at fair value through profit or loss
Dividends and interest 2,855 2,823
Interest received on Investment Management 181 -
fees reclaimed VAT
Other income not from financial assets 3 5
Other income 184 5
3,039 2,828
All investment income has been obtained from investments listed in the UK.
3 Management Fee
Year to 31 March 2009 Year to 31 March 2008
Revenue Capital Total Revenue Capital Total
£000 £000 £000 £000 £000 £000
Management fee 460 460 920 664 664 1,328
Irrecoverable VAT
thereon - - - 52 53 105
VAT reclaimed on
Investment Management fees (486) (399) (885) - - -
(26) 61 35 716 717 1,433
Performance fee - - - - - -
Irrecoverable VAT
thereon - - - - - -
VAT reclaimed on Performance fees - (247) (247) - - -
- (247) (247) - - -
The Manager receives a monthly fee equivalent to 1/12 of 1.0% of the gross
assets of the Company valued at the close of business on the last business day
of each month and is entitled to a performance fee calculated as described in
the Directors' Report above.
At 31 March 2009, £58,000 (2008: £98,000) was due for payment to the Manager.
The Company ceased to pay VAT on its Manager's fees from 10 October 2007 as a
result of the AIC/Claverhouse ruling. The refund of VAT in respect of
performance fees relates to fees paid in 2007, 2006 and 2001.
4 Other Expenses
Year to Year to
31 March 2009 31 March 2008
£000 £000
Administration and company secretarial fees 79 63
Auditor's remuneration (also see * below) for:
- audit 20 20
- other services to the Company 5 3
Other expenses (including Directors' remuneration and VAT) 230 226
334 312
* Total fees paid to the Auditor for the year, all of which were charged to revenue, comprised:
Audit services
- statutory audit 20 20
Tax services
- compliance services 5 3
25 23
The Directors do not consider that the provision of non-audit work to the Company affects the
independence of the Auditor.
5 Directors' Remuneration
Year to Year to
31 March 2009 31 March 2008
£000 £000
Total fees 85 85
A breakdown of the Directors' remuneration is set out in the Directors' Remuneration Report.
The Company has no employees.
6 Interest Payable and Similar Charges
Year to 31 March 2009 Year to 31 March 2008
Revenue Capital Total Revenue Capital Total
Financial liabilities not at fair
value through profit or loss £000 £000 £000 £000 £000 £000
Interest payable on loan 266 266 532 442 442 884
266 266 532 442 442 884
7 Taxation
The current taxation for the year is different to the standard rate of
corporation tax in the UK of 28% (2008: 30%). A reconciliation is provided
below:
Year to Year to
31 March 2009 31 March 2008
(restated)
£000 £000
Return on ordinary activities
before taxation (35,256) (22,228)
Theoretical corporation tax at 28% (2008: 30%) (9,872) (6,668)
Effects of:
- Capital losses that are not taxable 10,539 6,728
- UK dividend income not liable to corporation tax (730) (788)
- expenses disallowed for taxation purposes 9 6
- excess management expenses 54 722
Current taxation charge - -
At 31 March 2009, the Company had surplus management expenses and non-trade
losses of £20,575,810 (2008: £20,383,984), which have not been recognised as a
deferred taxation asset. This is because the Company is not expected to
generate taxable income in future periods in excess of the deductible expenses
of those future periods and, accordingly, it is unlikely that the Company will
be able to reduce future taxation through the use of existing surplus
expenses.
Due to the Company's status as an Investment Trust and the intention to
continue meeting the conditions required to obtain approval in the foreseeable
future, the Company has not provided deferred tax on any capital gains and
losses arising on the revaluation or disposal of investments.
8 Dividends
Year to Year to
31 March 2009 31 March 2008
£000 £000
Paid
2008 Final dividend of 3.65p
(2007: 2.65p) per ordinary share 1,227 944
Proposed
2009 Final dividend of 6.85p*
(2008: 3.65p) per ordinary share 2,293 1,227
* Including a non-recurring element of 1.99p
9 Return per Share
Year to 31 March 2009 Year to 31 March 2008
Revenue Capital Total Revenue Capital Total
Ordinary share 7.36p (112.54p) (105.18p) 3.82p (66.30p) (62.48p)
Revenue return per ordinary share is based on the net revenue after taxation
of £2,465,000 (2008: £1,358,000) and 33,518,244 (2008: 35,576,425) ordinary
shares, being the weighted average number of ordinary shares, excluding any
shares held in Treasury.
Capital return per ordinary share is based on net capital losses for the year
of £37,721,000 (2008: £23,586,000), and on 33,518,244 (2008: 35,576,425)
ordinary shares, being the weighted average number of ordinary shares,
excluding any shares held in Treasury.
10 Investments
Year to 31 March 2009 Year to 31 March 2008
£000 £000
Total investments at fair value 64,207 106,154
The investment portfolio comprises 61 listed UK equity holdings including 12
holdings totalling £12,541,000 (representing 20% of the portfolio) traded on
the Alternative Investment Market ("AIM").
Year Year to
to 31 March 2009 31 March 2008
£000 £000
Opening book cost 90,403 89,192
Opening fair value adjustment 15,751 48,250
Opening valuation 106,154 137,442
Movements in the year
Purchases at cost 14,251 28,234
Sales - proceeds (18,557) (37,095)
Sales - (losses)/ gains on sales (5,107) 10,072
Changes in fair value (32,534) (32,499)
Closing valuation 64,207 106,154
Closing book cost 80,990 90,403
Closing fair value adjustment (16,783) 15,751
64,207 106,154
TRANSACTION COSTS
During the year, the Company incurred transaction costs of £95,000 (2008:
£183,000) and £27,000 (2008: £59,000) on purchases and sales of investments,
respectively. These amounts are deducted in determining losses on investments
at fair value as disclosed in the Income Statement.
31 March 31 March
2009 2008
Total Total
`000 `000
Net losses on
investments
at fair value
though profit
or loss
(Losses)/gains on (5,107) 10,072
sales
Changes in fair (32,534) (32,499)
value
(37,641) (22,427)
A list of the top 50 investments by market value and an analysis of the
investment portfolio by industrial or commercial sector are set out at the
beginning of the report.
11 Significant Holdings
The Company has a holding of 3% or more of the voting rights attached to
shares that is material in the context of the accounts in the following
investments:
% of
Voting
Security rights
Zytronic PLC 4.7
The Stanley Gibbons Group PLC 3.6
Lok'n Store Group PLC 3.3
Latchways PLC 3.2
Carclo PLC 3.1
12 Debtors
31 March 2009 31 March 2008
£000 £000
Prepayments and accrued income 42 114
Dividends receivable 302 346
344 460
The carrying amount for prepayments, accrued income and dividends receivable
disclosed above reasonably approximates to its fair value at the year end and
is expected to be realised within a year from the balance sheet date.
13 Other Creditors
31 March 2009 31 March 2008
£000 £000
Accruals and deferred income 126 474
126 474
The carrying amount for accruals and deferred income disclosed above
reasonably approximates to its fair value at the year end and is expected to
be realised within a year from the balance sheet date.
14 Revolving Credit Facility
31 March 2009 31 March 2008
£000 £000
Falling due within one year 5,000 15,000
Falling due after more
than one year - -
5,000 15,000
The Company has a £15,000,000 Revolving Credit Facility with ING Bank N.V.
As at 31 March 2009, £5,000,000 was drawn down (31 March 2008: £15,000,000),
all of which has a fixed interest rate of 2.69%* and is repayable on 11
September 2009. The remaining £10,000,000 remains undrawn.
* Including margin and mandatory costs.
15 Share Capital
31 March 2009 31 March 2008
£000 £000
Authorised:
82,101,048 (2008: 82,101,048)
ordinary shares of 10p each 8,210 8,210
Allotted, called-up and fully paid*:
33,475,958 (2008: 35,449,458)
ordinary shares of 10p each 3,348 3,545
* including shares held in Treasury.
Voting rights
Ordinary shareholders have unrestricted voting rights at all general meetings
of the Company.
At the Annual General Meeting on 18 July 2008 the Company was granted the
authority to repurchase 5,313,874 ordinary shares. As at 31 March 2009 the
Company had remaining authority to repurchase 5,168,374 ordinary shares. This
authority is due to expire at the conclusion of the next Annual General
Meeting to be held on 31 July 2009.
During the year the following shares were purchased for cancellation:
% of
issued
share Total
capital cost of
Number of as at purchase
date of including
ordinary shares purchased purchase expenses
Date £000
11/07/2008 30,000 0.08 65
14/07/2008 30,000 0.08 65
15/07/2008 25,000 0.07 54
16/07/2008 10,000 0.03 21
18/07/2008 50,500 0.14 103
145,500 308
On 10 December 2008 1,828,000 shares held in Treasury were cancelled.
The Company does not have any externally imposed capital requirements. The
capital of the Company is managed in accordance with its investment policy in
pursuit of its investment objectives, both of which are detailed above.
16 Duration of the Company
The Articles of Association prescribe that shareholders should have the
opportunity to consider the future of the Company at regular intervals. At the
Annual General Meeting to be held on 31 July 2009 an Ordinary Resolution will
be proposed to release the Directors from the obligation to convene a General
Meeting during 2010 for the purpose of voluntarily winding up the Company, as
provided for in the Company's Articles of Association. If the Company is not
wound up, such Resolution will be proposed at a General Meeting every five
years thereafter unless, at any AGM held within, and not more than, 18 months
prior to the expiry of the relevant period of five years, an Ordinary
Resolution is passed releasing the Directors from the obligation to convene
such a General Meeting.
17 Own Shares Held in Treasury
The Company has taken advantage of the regulations which came into force on 1
December 2003 to allow companies, including investment trusts, to buy its own
shares and hold them in Treasury for re-issue at a later date. The shares
previously held in Treasury were cancelled on 10 December 2008. No shares were
placed in Treasury during the year. The maximum number of shares held at any
time during the year was 1,828,000, representing 5.18% of the issued Capital.
Year to 31 March 2009 Year to 31 March 2008
Own shares Premium on Own shares Premium on
held in Treasury disposal held in Treasury disposal
SUMMARY Number £000 £000 Number £000 £000
At 1 April 1,828,000 4,501 - - - -
Additions - - - 1,828,000 4,501 -
Cancellation - book cost (1,828,000) (4,501) - - - -
Disposals - book cost - - - - - -
At 31 March - - - 1,828,000 4,501 -
18 Net Asset Value per Ordinary Share
Net asset value per ordinary share is based on net assets of £65,592,000
(2008: £102,383,000) and on 33,475,958 (2008: 33,621,458) ordinary shares
being the number of ordinary shares in issue at the year end.
19 Reconciliation of Net Revenue Before Finance Costs
and Taxation to Net Cash Inflow from Operating Activities
Year to 31 March 2009 Year to 31 March 2008
£000 £000
Net revenue before finance
costs and taxation 2,731 1,800
Management fee charged to capital (460) (717)
VAT reclaim on Investment
Management Fees charged to capital 646 -
Decrease in creditors (45) (910)
Decrease/(increase) in prepayments
and accrued income 110 (43)
Net cash inflow from
operating activities 2,982 130
20 Reconciliation of Net Cash Flows to Movements in Net Cash/(Debt)
Year to 31 March 2009 Year to 31 March 2008
£000 £000
(Decrease)/increase in cash in year (5,076) 6,883
Proceeds of credit facility - (4,500)
Repayment of credit facility 10,000 -
Movement in net funds 4,924 2,383
Net debt at beginning of year (3,757) (6,140)
Net cash/(debt) at end of year 1,167 (3,757)
ANALYSIS OF NET CASH/(DEBT)
1 April 2008 Cash flows 31 March 2009
£000 £000 £000
Cash at bank 11,243 (5,076) 6,167
Debt due in less than one year (15,000) 10,000 (5,000)
Debt due after one year - - -
(3,757) 4,924 1,167
21 Analysis of Financial Assets and Liabilities
As required by FRS 29: "Financial Instruments: Disclosures", an analysis of
financial assets and liabilities, which identifies the risk to the Company of
holding such items, is given below.
BACKGROUND
The Company's financial instruments comprise securities, cash balances and
debtors and creditors that arise from its operations, for example, in respect
of sales and purchases awaiting settlement and debtors for accrued income.
The risk management policies and procedures outlined in this note have not
changed substantially from the previous accounting period.
The Company has little or no exposure to cash flow or foreign currency risk.
The principal risks the Company faces in its portfolio management activities
are:
- credit risk;
- market price risks, i.e. movements in the value of investment holdings
caused by factors other than interest rate or currency movement;
- interest rate risk;
- liquidity risk i.e. the risk that the Company has difficulty in realising
assets or otherwise raising funds to meet commitments associated with
financial instruments; and
- gearing.
The Manager monitors the financial risks affecting the Company on a daily
basis. The Directors receive financial information on a monthly basis which is
used to identify and monitor risk.
(i) Credit Risk
Credit risk is the risk of financial loss to the Company if the contractual
party to a financial instrument fails to meet its contractual obligations.
The carrying amounts of financial assets best represent the maximum credit
risk exposure at the balance sheet date.
The Company's listed investments are held on its behalf by HSBC acting as
agent, the Company's custodian. Bankruptcy or insolvency of the custodian may
cause the Company's rights with respect to securities held by the custodian to
be delayed. The Board monitors the Company's risk by reviewing the custodian's
internal controls reports.
Investment transactions are carried out with a large number of brokers whose
creditworthiness is reviewed by the Manager. Transactions are ordinarily
undertaken on a delivery versus payment basis whereby the Company's custodian
bank ensures that the counterparty to any transaction entered into by the
Company has delivered in its obligations before any transfer of cash or
securities away from the Company is completed.
The banks at which cash is held are under constant review.
The maximum exposure to credit risk at 31 March 2009 was:
31 March 2009 31 March 2008
£000 £000
Cash at bank 6,167 11,243
Debtors and prepayments 344 460
6,511 11,703
None of the Company's assets are past due or impaired.
(ii) Market Price Risk
Market price risk arises mainly from uncertainty about future prices of
financial instruments. The value of shares and the income from them may fall
as well as rise and shareholders may not get back the full amount invested.
The Manager continues to monitor the prices of financial instruments held by
the Company on a real time basis. Adherence to the Company's investment
objectives mitigates the risk of excessive exposure to one issuer or sector.
The Board manages the market price risks inherent in the investment portfolio
by ensuring full and timely access to relevant information from the Investment
Manager. The Board meets regularly and each meeting reviews the investment
performance, the investment portfolio and the rationale for the current
investment positioning to ensure consistency with the Company's objectives and
investment policies. The portfolio does not seek to reproduce the index,
investments are selected based upon the merit of individual companies and
therefore the portfolio may well diverge from the short term fluctuations of
the benchmark.
Fixed asset investments are valued at their bid price which equates to their
fair value. A list of the Company's 50 largest equity investments shown at
beginning of announcement. In addition, an analysis of the investment
portfolio by broad industrial and commercial sector, an analysis of the
portfolio by market capitalisation of holdings and a list of the 30 largest
equity investments are contained in the Managers' Review section.
The maximum exposure to market price risk is the fair value of investments of
£64,207,000 (2008: £106,154,000).
If the investment portfolio valuation fell by 1% from the amount detailed in
the financial statements as at 31 March 2009 it would have the effect, with
all other variables held constant, of reducing the net capital return before
taxation by £642,000 (2008: £1,062,000). An increase of 1% in the investment
portfolio valuation would have an equal and opposite effect on the net capital
return before taxation.
(iii) Interest Rate Risk
Changes in interest rates may cause fluctuations in the income and
expenses of the Company. The revolving credit facility with ING Bank N.V. is a
fixed rate facility (see note 14). The amount of such borrowings and the
approved levels are monitored and reviewed regularly by the Board. The Company
mitigates the risk by fixing the interest rates of the facility for six months
at a time.
The Company receives interest on the cash deposits at a rate of
0.5% below the bank base rate. The interest received in the year amounted to
£247,000 (2008: £195,000).
The interest risk profile of the Company is given below.
If interest rates had reduced by 1% from those paid as at 31 March 2009 it
would have the effect, with all other variables held constant, of increasing
the net revenue return before taxation on an annualised basis by £50,000
(2008: £150,000). If there was an increase in interest rates of 1% there would
have been an equal and opposite effect in the net revenue return before
taxation. The calculations are based on cash at bank and short-term deposits
as at 31 March 2009 and these may not be representative of the year as a
whole.
Due to the short-term nature of the loan facility, changes in interest rates
would not have an effect on the fair value of the loan.
(iv) Liquidity Risk
Liquidity is the risk that the Company will encounter difficulty in meeting
obligations associated with financial liabilities. The Manager does not invest
in unlisted securities on behalf of the Company. However, the investments held
by the Company consist of UK quoted small companies which are inherently less
liquid than quoted large companies. Short-term flexibility is achieved through
the use of bank borrowings. Liquidity risk is mitigated by the fact that the
Company has £6.2 million cash at bank which can satisfy its creditors and that
as a closed end fund assets do not need to be liquidated to meet redemptions.
(v) Gearing
Gearing can have amplified effects on the net asset value of the Company. It
can have a positive or negative effect depending on market conditions. It is
the Company's policy to determine the adequate level of gearing appropriate to
its own risk profile.
(vi) Use of Derivatives
It is not the Company's policy to enter into derivative contracts.
FINANCIAL ASSETS
The majority of the Company's financial assets are listed equity shares which
neither pay interest nor have a maturity date. No fixed interest assets were
held at 31 March 2009 nor during the year.
All financial assets are in sterling and disclosed at fair value through
profit or loss.
FINANCIAL LIABILITIES
The Company finances its operations through equity, retained profits and bank
borrowings (see note 14). The change in the fair value of financial
liabilities during the year was not related to the credit risk profile. The
interest rate risk profile of the financial liabilities of the Company as at
31 March 2009 is as follows:
Weighted average Period until
Total interest rate maturity
£000 % Years
Amounts drawn down
under fixed revolving
credit facility 5,000 5.5338 0.45
Financial liabilities
upon which no interest is paid 126 - -
The interest rate risk profile of the financial liabilities of the Company as
at 31 March 2008 was as follows:
Total Weighted average Period until
£000 interest rate maturity
% Years
Amounts drawn down
under fixed revolving credit facility 15,000 6.1203 0.33
Financial liabilities upon which no
interest is paid 474 - -
The maturity profile of the Company's financial liabilities is as follows:
As at 31 March 2009 As at 31 March 2008
£000 £000
In one year or less 5,126 15,474
In more than one but not
more than two years - -
In more than two years
but not more than five years - -
5,126 15,474
The Company had £10,000,000 undrawn under the fixed Revolving Credit Facility
at 31 March 2009 (2008: £10,000,000).
The Company's fixed revolving credit facility is measured at cost and
denominated in sterling. All other financial liabilities are in sterling and
disclosed at fair value. It is considered that, because of the short term
nature of the facility, cost approximates to fair value.
22 Previous Commitments and Contingent Liabilities
At 31 March 2009, there were no capital commitments (2008: nil).
23 Related Party Transactions
Under the Listing Rules the Manager is regarded as a related party of the
Company. The amounts paid to the Manager are disclosed in note 3. However, the
existence of an independent Board of Directors demonstrates that the Company
is free to pursue its own financial and operating policies, and therefore, in
terms of FRS 8: "Related Party Transactions", the Manager is not considered a
related party. The relationship between the Company, its Directors and the
Manager is disclosed in the Directors' Report.
Company Summary
Investment Objective
MUSCIT's investment objective is capital appreciation (rather than income)
achieved by investing in small quoted companies listed on the London Stock
Exchange or traded on the Alternative Investment Market ("AIM") and to achieve
relative outperformance of its benchmark, the FTSE SmallCap (excluding
investment companies) Index ("SmallCap").
No unquoted investments are permitted.
Investment Policy
The Company seeks to achieve its investment objective by investing in a
portfolio of quoted UK Smaller Companies. At the time of initial investment, a
potential investee company must be profitable and smaller than the largest
constituent of the HGSC Index, which represents the smallest 10% of the UK
Stock Market by value. At the start of 2009, this was any company below £911
million in size. The Manager focuses on the smaller end of this Index.
In order to manage risk the Manager will normally limit any one holding to a
maximum of 5% of the Company's investments. The portfolio weightings of every
stock are closely monitored to ensure they reflect the underlying liquidity of
the particular company. The Company's AIM exposure is also closely monitored
by the Board and is limited to 30% of total investments with Board approval
required for exposure to be above 25%.
The Manager is focused on identifying high quality niche companies operating
in growth markets. This typically leads the Manager to invest in companies
that enjoy high barriers to entry, a sustainable competitive advantage and
strong management teams. The portfolio is therefore constructed on a "bottom
up" basis and there are no sectoral constraints placed on the Manager.
The Board, in consultation with the Manager, is responsible for determining
the gearing strategy of the Company. Gearing is used to enhance returns when
the timing is considered appropriate. The Company currently has a credit
facility of £15 million through ING Bank. The Board has agreed to limit
borrowings to 25% of shareholders' funds.
Benchmark
FTSE SmallCap (excluding investment companies) Index ("SmallCap").
Gross Assets
£70,718,000 as at 31 March 2009.
Shareholders' Funds
£65,592,000 as at 31 March 2009.
Market Capitalisation
£51,218,000 as at 31 March 2009.
Capital Structure
As at 31 March 2009 and at the date of this report, the Company had 33,475,958
ordinary shares of 10p each in issue (of which none were held in Treasury).
Wind up Date
In accordance with the Articles of Association, an Ordinary resolution will to
be put to shareholders at the Annual General Meeting to be held on 31 July
2009 to release the Directors from the obligation to convene a General Meeting
in 2010 for the purpose of winding up the Company.
Management Fee
The management fee comprises two components: a fixed fee of 1/12 of 1% of the
gross assets of the Company, payable monthly in arrears, and a performance fee
of 0.1% of the gross assets of the Company for each 1% outperformance (or part
thereof) of the Company's NAV against the SmallCap over the financial year,
subject to a maximum of 0.5% of the gross assets calculated at the end of the
financial year.
Administration and Company Secretarial Fees
The Company Secretary receives an annual fee of £79,000, which is subject to
an annual RPI uplift. The Company ceased to pay VAT on its Administration and
Company Secretarial Fees in October 2008.
Sources of Information
All information contained within the Chairman's Statement and the Manager's
Report has been provided by Montanaro Investment Managers Limited unless
otherwise noted.